Serum CHI3LI and CHI3L2 levels in detecting disease activity and prognosis in multiple sclerosis patients

dc.contributor.authorTasdemir, N.
dc.contributor.authorDegirmenci, B.
dc.date.accessioned2024-04-24T16:15:11Z
dc.date.available2024-04-24T16:15:11Z
dc.date.issued2019
dc.departmentDicle Üniversitesien_US
dc.descriptionWorld Congress of Neurology (WCN) -- OCT 27-31, 2019 -- Emirates Neurol Soc, Dubai, U ARAB EMIRATESen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipWorld Federat Neurolen_US
dc.identifier.doi10.1016/j.jns.2019.10.1197
dc.identifier.issn0022-510X
dc.identifier.issn1878-5883
dc.identifier.urihttps://doi.org/10.1016/j.jns.2019.10.1197
dc.identifier.urihttps://hdl.handle.net/11468/15693
dc.identifier.volume405en_US
dc.identifier.wosWOS:000516770700410
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofJournal of The Neurological Sciences
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleSerum CHI3LI and CHI3L2 levels in detecting disease activity and prognosis in multiple sclerosis patientsen_US
dc.titleSerum CHI3LI and CHI3L2 levels in detecting disease activity and prognosis in multiple sclerosis patients
dc.typeConference Objecten_US

Dosyalar